Multi-licensed UK and EU medical cannabis importer and distributor seeks strategic equity partner!

Phase 1: UK Market Dominance

• Continued import and distribution of high-quality, cost-effective, branded cannabis flower and oil products for UK medical cannabis patients via established UK pharmacy contracts and new clinic and private hospital partnerships.

• Exclusive relationships with top-ranked Canadian producers for a custom product line.

• Strong customer satisfaction with products ranking #1 on UK Reddit and a nomination for Producer of the Year Cannabis Europa.

• Rapid revenue growth with 900% increase since August 2024.

• Projected UK sales of £2-3 million/month supported by scale-up.

• Development and sale of new readily consumable product forms.

• Experienced, industry-leading international team with deep expertise in navigating global medical cannabis markets.

• Existing sales of £900K/month in 2025, with plans to grow to £2M/month in 2026 and £3M/month in 2027.

Phase 2: EU Market Expansion

• Unlock international distribution with a new UK/Guernsey Distribution Hub for the EU, leveraging a tax-friendly jurisdiction to speed up cross-border logistics and position the company as a licensed importer into major EU markets.

• Projected EU revenue of £50 million in 5 years from the new Guernsey facility and expanded distribution.

• Expansion of wholesale distribution of branded cannabis flower, oils, and derivative products to European Union markets.

• Focus on driving down Cost of Goods Sold (COGS) through cash purchases and GACP Direct importing.

• Add new co-packing revenue streams.

Key Barriers to Entry:

• Scarce licensing.

• Established relationships with suppliers.

• Unique relationships with customers and patients.